StockData
TransMedics Group, Inc. logo

TransMedics Group, Inc. (TMDX) stock

TMDXNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 14/3029% below fair value
$93.91+1.70 (+1.84%)

Close on Nov 17, 2026Market cap $3.26BP/E 24.4Yield 0.00%

TransMedics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

TransMedics's price to sales ratio was 4.8× on Nov 11, 2026, against 8.8× a year earlier. Over the last 5 years it ranged from 3.4× to 28.9×, with a median of 12.7×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20264.8×−2.6
2025Dec 31, 20257.3×+2.1
2024Dec 31, 20245.2×−8.2
2023Dec 29, 202313.4×−14.0
2022Dec 30, 202227.5×+8.6
2021Dec 31, 202118.9×−3.6
2020Dec 31, 202022.5×+14.1
2019Dec 31, 20198.4×–

More TransMedics figures

See a number that looks wrong?